Citigroup Maintains Buy on Eli Lilly, Raises Price Target to $675
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Andrew Baum maintains a Buy rating on Eli Lilly (NYSE:LLY) and raises the price target from $525 to $675.
October 23, 2023 | 3:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Eli Lilly and raises the price target from $525 to $675, which could positively impact the stock's price.
The raised price target by Citigroup indicates a positive outlook for Eli Lilly. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100